Article
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma
1 Feb 2020
Abstract excerpt
PURPOSE: As a crucial part of anti-tumor immunotherapy, interferon-α/β (IFN-α/β) treatment has been broadly applied to clinical trials of glioma. However, less is known about implement of interferon-γ (IFN-γ) in glioma. Further investigating the valuable hub molecular of IFN-γ family might provide us a novel guidance for glioma therapy. METHODS: This study carried out an analysis on glioma patients from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
